Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Sep;23(5):458-467.
doi: 10.1097/MCP.0000000000000409.

Ocular sarcoidosis: new diagnostic modalities and treatment

Affiliations
Review

Ocular sarcoidosis: new diagnostic modalities and treatment

Sung J Yang et al. Curr Opin Pulm Med. 2017 Sep.

Abstract

Purpose of review: Ocular involvement in sarcoidosis is present in up to 80% of patients and is frequently manifested before diagnosis of the underlying systemic disease. Considering the therapeutic consequences, early diagnosis of the underlying disease is advantageous in patients presenting with ocular inflammation. There are several ocular findings suggestive of underlying sarcoidosis, such as granulomatous keratic precipitates, iris nodules, cells in the vitreous humor known as snowballs and snowbanks, and retinal periphlebitis. High suspicion is crucial for the diagnosis of sarcoidosis. This review on ocular sarcoidosis will mainly focus on new diagnostic and treatment modalities.

Recent findings: Recent studies found possible new diagnostic indicators for the diagnosis of ocular sarcoidosis which include not only serum profiles but also vitreous sample analysis. Ophthalmologic imaging techniques have improved to investigate the ocular structure in detail. Results from recent uveitis clinical trials have included sarcoidosis as an underlying cause and have reported positive results.

Summary: The diagnosis of ocular sarcoidosis can be challenging in some cases. High suspicion is important to diagnose ocular sarcoidosis with various laboratory and ophthalmic tools. There are many possible options for the treatment of ocular sarcoidosis including various biologic agents.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

None.

Figures

Figure 1
Figure 1. wide field color fundus photo (A) and wide field fundus autofluorescence (B)
Color fundus photo(A) shows multiple yellowish spots (sarcoid spots) whereas autofluorescence (B) shows more mall black (hypofluorescence) spots compared to color fundus photo. This indicates there are more retinal pigmentary change due to outer retinal and choroidal inflammation as seen in color fundus photo and fundus examination.
Figure 2
Figure 2. wide field fundus photo and fluorescein angiography
Figure A indicates the area covering conventional photography. Wide field photo can reveal far peripheral retinal lesion (B, white arrow) and vascular Leakage (C, white arrows) and enables the diagnosis of peripheral chorioretinal lesions and vasculitis. It also determines the extent of affected area.
Figure 3
Figure 3. Wide field fundus autofluorescence of left eye
This patient denied any deterioration of left eye vision, but there was increased hyperfluorescence intensity (B) temporal and inferotemporal to the macular area (white arrows) compared to previous visit(A). This finding can reflect active subclinical inflammation
Figure 4
Figure 4. Optical coherence tomography (OCT) with cystoid macular edema
A. The area indicated by white arrow shows several black cystic spaces (cystoid macular edema). Intraretinal fluid accumulation due to inflammation result in retinal thickening and visual deterioration. B. The cystoid macular edema resolved after the treatment. OCT shows normal concave health macular contour. OCT is useful imaging tool for detection of macular edema and assessing treatment response.

References

    1. Radosavljevic A, Jaksic V, Pezo L, et al. Clinical features of ocular sarcoidosis in patients with biopsy-proven pulmonary sarcoidosis in serbia. Ocul Immunol Inflamm. 2016:1–5. - PubMed
    1. Ibitoye RT, Wilkins A, Scolding NJ. Neurosarcoidosis: a clinical approach to diagnosis and management. J Neurol. 2016 - PMC - PubMed
    1. Jabs DA, Nussenblatt RB, Rosenbaum JT, et al. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516. - PMC - PubMed
    1. Davis JL, Madow B, Cornett J, et al. Scale for photographic grading of vitreous haze in uveitis. Am J Ophthalmol. 2010;150:637–641. e631. - PMC - PubMed
    1. Babu K, Kini R, Mehta R. Scleral nodule and bilateral disc edema as a presenting manifestation of systemic sarcoidosis. Ocul Immunol Inflamm. 2010;18:158–161. - PubMed